Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-010652
Filing Date
2021-05-06
Accepted
2021-05-06 17:12:33
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 459544
2 ex31-1.htm EX-31.1 8663
3 ex31-2.htm EX-31.2 8683
4 ex32-1.htm EX-32.1 5163
5 ex32-2.htm EX-32.2 5210
  Complete submission text file 0001493152-21-010652.txt   3117477

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mrzm-20210331.xml EX-101.INS 477938
7 XBRL SCHEMA FILE mrzm-20210331.xsd EX-101.SCH 34363
8 XBRL CALCULATION FILE mrzm-20210331_cal.xml EX-101.CAL 44157
9 XBRL DEFINITION FILE mrzm-20210331_def.xml EX-101.DEF 138248
10 XBRL LABEL FILE mrzm-20210331_lab.xml EX-101.LAB 270013
11 XBRL PRESENTATION FILE mrzm-20210331_pre.xml EX-101.PRE 224671
Mailing Address 225 CHIMNEY CORNER LANE, STE 2001 JUPITER FL 33458
Business Address 225 CHIMNEY CORNER LANE, STE 2001 JUPITER FL 33458 732-723-7395
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

EIN.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53223 | Film No.: 21898918
SIC: 2834 Pharmaceutical Preparations